What Is a Ketamine Troche?
A ketamine troche is a small, medicated lozenge designed to dissolve slowly under the tongue or between the cheek and gum. Unlike a typical candy lozenge you might use for a sore throat, a ketamine troche is a precisely compounded pharmaceutical product containing ketamine hydrochloride as its active ingredient. When placed in the mouth, it dissolves over 10 to 20 minutes and delivers ketamine directly into the bloodstream through the mucous membranes of the mouth — a process called sublingual or buccal absorption.
Troches have been used in medicine for decades to deliver hormones, pain medications, and other compounds that benefit from avoiding the digestive system. Ketamine troches represent a newer application of this well-established delivery system, offering patients a way to receive ketamine therapy at home rather than in a clinic.
How Are Ketamine Troches Different From Other Medications?
Most medications you take by mouth — capsules, tablets, liquids — travel through your stomach and intestines before entering your bloodstream. This process, called first-pass metabolism, means the liver breaks down a significant portion of the drug before it ever reaches its target. For ketamine taken orally and swallowed, bioavailability drops to roughly 16 to 20 percent because the liver metabolizes it so aggressively.
A troche bypasses first-pass metabolism entirely. Because the ketamine is absorbed through the mucosal tissue directly into small blood vessels in the mouth, it enters systemic circulation without passing through the liver first. This raises bioavailability to approximately 20 to 30 percent — a meaningful improvement over swallowing the same dose.
Key Differences From IV Ketamine
Intravenous ketamine delivers 100 percent bioavailability because it goes directly into the bloodstream. A troche is less bioavailable but offers significant practical advantages: no needle, no clinic visit required, lower cost, and the ability to use it in a comfortable home environment. For maintenance therapy and many outpatient protocols, this tradeoff is acceptable and even preferred.
Why Do Doctors Prescribe Ketamine Troches?
Ketamine was FDA-approved in 1970 as an anesthetic agent, and its antidepressant and analgesic properties have been studied extensively since the late 1990s. Physicians prescribe ketamine troches off-label for several conditions:
- Treatment-resistant depression (TRD): Patients who have not responded to two or more antidepressants may benefit from ketamine's rapid-acting antidepressant effects, often felt within hours to days rather than the weeks required by traditional antidepressants.
- Anxiety disorders: Including generalized anxiety disorder, social anxiety, and PTSD, where ketamine's glutamate modulation may interrupt entrenched fear circuits.
- Chronic pain: Particularly neuropathic pain, complex regional pain syndrome (CRPS), and fibromyalgia, where ketamine acts on NMDA receptors involved in central sensitization.
- Suicidal ideation: Ketamine has shown rapid antisuicidal effects in research settings, making it valuable for acute crisis management under careful medical supervision.
What's Inside a Ketamine Troche?
The active ingredient is ketamine hydrochloride (ketamine HCl). The troche base — the inert carrier material — is typically a mixture of polyethylene glycol (PEG), gelatin, or other compounds that allow the lozenge to dissolve slowly and remain stable over its shelf life. Most compounding pharmacies add flavoring agents (common options include mint, cherry, and grape) to improve palatability, since ketamine has a naturally bitter, chemical taste.
Some formulations include preservatives to extend shelf life, though many compounding pharmacies produce preservative-free versions for patients with sensitivities.
Typical Dosage Range
Ketamine troches for mental health applications are most commonly compounded at doses between 100 mg and 400 mg of ketamine HCl per troche. The typical starting dose for a new patient is often 100 mg to 200 mg, with titration upward based on response and tolerability. For chronic pain management, doses may be lower, often in the 50 mg to 150 mg range.
The Compounding Pharmacy Connection
Ketamine troches are not commercially manufactured products — they don't come from a factory making identical pills at scale. Instead, they are custom-compounded by licensed compounding pharmacies to meet the specifications of an individual prescription. A physician determines the dose, and the pharmacy creates the troches to match that exact prescription.
This means the quality, consistency, and potency of a ketamine troche depends heavily on the compounding pharmacy's standards, equipment, and oversight. Reputable pharmacies hold accreditation from organizations like the Pharmacy Compounding Accreditation Board (PCAB) and follow USP Chapter 795 guidelines for non-sterile compounding.
Who Typically Prescribes Ketamine Troches?
Psychiatrists are the most common prescribers, given that the majority of ketamine troche patients are seeking treatment for mental health conditions. However, pain management specialists, anesthesiologists, and some primary care physicians also prescribe them when appropriate. With the growth of telehealth, a number of specialized telemedicine platforms now connect patients with licensed prescribers who can evaluate candidates and manage ketamine troche therapy remotely.
Prescribers typically conduct a thorough intake evaluation that includes a review of psychiatric history, current medications, medical history, and cardiovascular status before initiating a prescription.
Is a Troche Right for You?
Not everyone is a candidate for ketamine troche therapy. People with uncontrolled hypertension, a history of psychosis, active mania, or certain cardiovascular conditions may not be appropriate candidates. A thorough evaluation with a qualified prescriber is the essential first step.
If you've been struggling with treatment-resistant depression, chronic anxiety, PTSD, or difficult-to-control pain and haven't found relief through conventional approaches, a conversation with a provider about ketamine troche therapy may be worthwhile. The availability of telehealth options has made accessing this evaluation more feasible than ever for patients outside major metropolitan areas.
Key Takeaways
- A ketamine troche is a compounded sublingual lozenge containing ketamine HCl.
- It delivers ketamine through oral mucosal absorption, bypassing liver first-pass metabolism.
- Bioavailability is approximately 20 to 30 percent, compared to less than 20 percent when swallowed orally.
- Doctors prescribe it off-label for treatment-resistant depression, anxiety, PTSD, and chronic pain.
- Quality depends on the compounding pharmacy — look for PCAB-accredited providers.
- A thorough medical evaluation is required before starting ketamine troche therapy.
References
- StatPearls: Ketamine — Comprehensive clinical reference on ketamine pharmacology, mechanisms of action, and therapeutic applications
- PubChem: Ketamine Compound Summary — NCBI chemical database entry with ketamine molecular data, pharmacokinetics, and bioactivity profiles
- MedlinePlus: Ketamine — National Library of Medicine consumer drug information on ketamine including uses, proper administration, and precautions
- NIMH: Depression — National Institute of Mental Health overview of depressive disorders, treatment-resistant forms, and emerging therapies
- WHO: Depression Fact Sheet — World Health Organization global data on depression prevalence, burden, and treatment approaches
Share